Researchers to study whether plasma of recovered patients can treat COVID-19Researchers from across Canada will collaborate on a vast clinical trial to study whether the plasma of recovered patients can be used to treat COVID-19. Five specific steps to help ease COVID-19 anxiety among frontline healthcare professionalsAbove all, express genuine gratitude for healthcare professionals’ commitment to caring for patients with COVID-19 COVID-19: Effects in children Although originally thought to be harmless in children, there is increasing evidence that children are not completely invulnerable to COVID-19 Science summary: A look at novel coronavirus research around the globe Thousands of scientists around the world are working on problems raised by the COVID-19 pandemic. Here is a summary of some recent research from peer-reviewed academic journals and scientific agencies... US FDA authorizes use of chloroquine/hydroxychloroquine for emergency treatment of COVID-19 in hospitalized patients National emergency stockpile supply of chloroquine/hydroxychloroquine can be used, but only when participation in clinical trials is not feasible Convalescent plasma: a potential treatment for critically ill patients with COVID-19 Early case series results show some promise, but further study required in controlled clinical trials COVID-19: Reasons to discourage off-label drug treatments Randomized controlled trials are the only way to find effective and safe treatments for COVID-19 Hydroxychloroquine for COVID-19 prevention or treatment lacks clinical evidence Pharmacy and medical organizations issue statements to discourage off-label prescribing No proof that NSAIDs, ACE inhibitors or angiotensin II blockers can worsen the effects of COVID-19 Professional organizations issue statements to counteract misinformation circulating in the media and on social media Aerosol and fomite transmission SARS-CoV-2 is plausible NEJM: presence in aerosol of SARS-CoV-2 similar to that of CoV-1 First Previous 67 68 69 70 71 Next Last
